{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:40:04Z","timestamp":1792694404443,"version":"4.5.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T00:00:00Z","timestamp":1393200000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2415-14-18","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T10:02:14Z","timestamp":1393236134000},"source":"Crossref","is-referenced-by-count":21,"title":["Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report"],"prefix":"10.1186","volume":"14","author":[{"given":"Thomas P","family":"Moloney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher","family":"Rallah-Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niara","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathon J","family":"Farrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,24]]},"reference":[{"key":"392_CR1","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/S0140-6736(00)02074-2","volume":"355","author":"J Crown","year":"2000","unstructured":"Crown J, O\u2019Leary M: The taxanes: an update. Lancet. 2000, 355: 1176-1178. 10.1016\/S0140-6736(00)02074-2.","journal-title":"Lancet"},{"key":"392_CR2","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1200\/JCO.1999.17.3.1061","volume":"17","author":"C Dumontet","year":"1999","unstructured":"Dumontet C, Sikic BI: Mechanisms of action of and resistance to antitubulin agents: microtubule dynamics, drug transport, and cell death. J Clin Oncol. 1999, 17: 1061-1070.","journal-title":"J Clin Oncol"},{"issue":"Suppl 6","key":"392_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/annonc\/mdt284","volume":"24","author":"E Senkus","year":"2013","unstructured":"Senkus E, Kyriakides S, Penault-Llorca F, Poortmans P, Thompson A, Zackrisson S, Cardoso F: Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013, 24 (Suppl 6): 7-23.","journal-title":"Ann Oncol"},{"key":"392_CR4","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1592\/phco.26.6.853","volume":"26","author":"PE Kintzel","year":"2006","unstructured":"Kintzel PE, Michaud LB, Lange MK: Docetaxel-associated epiphora. Pharmacotherapy. 2006, 26: 853-867. 10.1592\/phco.26.6.853.","journal-title":"Pharmacotherapy"},{"key":"392_CR5","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3816\/CBC.2005.n.004","volume":"5","author":"B Esmaeli","year":"2005","unstructured":"Esmaeli B: Management of excessive tearing as a side effect of docetaxel. Clin Breast Cancer. 2005, 5: 455-457. 10.3816\/CBC.2005.n.004.","journal-title":"Clin Breast Cancer"},{"key":"392_CR6","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/cncr.11527","volume":"98","author":"B Esmaeli","year":"2005","unstructured":"Esmaeli B, Hidaji L, Adinin RB, Faustina M, Coats C, Arbuckle R, Rivera E, Valero V, Tu SM, Ahmadi MA: Blockage of the lacrimal drainage apparatus as a side effect of docetaxel therapy. Cancer. 2005, 98: 504-507.","journal-title":"Cancer"},{"key":"392_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1146\/annurev.med.48.1.353","volume":"48","author":"EK Rowinsky","year":"1997","unstructured":"Rowinsky EK: The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents. Annu Rev Med. 1997, 48: 353-374. 10.1146\/annurev.med.48.1.353.","journal-title":"Annu Rev Med"},{"key":"392_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/00006324-200304000-00004","volume":"80","author":"BA Teitelbaum","year":"2003","unstructured":"Teitelbaum BA, Tresley DJ: Cystic maculopathy with normal capillary permeability secondary to docetaxel. Optom Vis Sci. 2003, 80: 277-279. 10.1097\/00006324-200304000-00004.","journal-title":"Optom Vis Sci"},{"key":"392_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1080\/08820530701457373","volume":"22","author":"DG Telander","year":"2007","unstructured":"Telander DG, Sarraf D: Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome. Semin Ophthalmol. 2007, 22: 151-153. 10.1080\/08820530701457373.","journal-title":"Semin Ophthalmol"},{"key":"392_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s11060-005-9008-x","volume":"77","author":"V Scaioli","year":"2006","unstructured":"Scaioli V, Caraceni A, Martini C, Curzi S, Capri G, Luca G: Electrophysiological evaluation of visual pathways in paclitaxel-treated patients. J Neurooncol. 2006, 77: 79-87. 10.1007\/s11060-005-9008-x.","journal-title":"J Neurooncol"},{"key":"392_CR11","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1093\/jnci\/86.14.1099","volume":"86","author":"G Capri","year":"1994","unstructured":"Capri G, Munzone E, Tarenzi E, Fulfaro F, Gianni L, Caraceni A, Martini A, Scaioli V: Optic nerve disturbances: a new form of paclitaxel neurotoxicity. J Natl Cancer Inst. 1994, 86: 1099-1101. 10.1093\/jnci\/86.14.1099.","journal-title":"J Natl Cancer Inst"},{"key":"392_CR12","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0910383","volume":"365","author":"D Slamon","year":"2011","unstructured":"Slamon D, Eiermann W, Robert N, Pienkowski T, Martin M, Press M, Mackey J, Glaspy J, Chan A, Pawlicki M, Pinter T, Valero V, Liu MC, Sauter G, von Minckwitz G, Visco F, Bee V, Buyse M, Bendahmane B, Tabah-Fisch I, Lindsay MA, Riva A, Crown J for the Breast Cancer International Research Group: Adjuvant trastuzumab in HER2-positive breast cancer. N Engl J Med. 2011, 365: 1273-1283. 10.1056\/NEJMoa0910383.","journal-title":"N Engl J Med"},{"key":"392_CR13","first-page":"1098","volume":"22","author":"RD Mosteller","year":"1987","unstructured":"Mosteller RD: Simplified calculation of body-surface area. N Eng J Med. 1987, 22: 1098-","journal-title":"N Eng J Med"},{"key":"392_CR14","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1056\/NEJMoa052258","volume":"353","author":"B Thurslimann","year":"2005","unstructured":"Thurslimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF, Paridaens R, Catiglione-Gertsch M, Gelber R, Rabaglio M, Smith I, Wardly A, Price KN, Goldhirsch A: A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer (BIG 1-98 trial). N Engl J Med. 2005, 353: 2747-2757.","journal-title":"N Engl J Med"},{"key":"392_CR15","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/WNO.0b013e3182901969","volume":"33","author":"M Wang","year":"2013","unstructured":"Wang M, Sadun A: Drug-related mitochondrial optic neuropathies. J Neuro-Ophthalmol. 2013, 33: 172-178. 10.1097\/WNO.0b013e3182901969.","journal-title":"J Neuro-Ophthalmol"},{"key":"392_CR16","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3109\/0284186X.2011.555781","volume":"50","author":"M Saleh","year":"2011","unstructured":"Saleh M, Bourcier T, Noel G, Speeg-Schatz C, Gaucher D: Bilateral macular ischemia and severe visual loss following trastuzumab therapy. Acta Oncol. 2011, 50: 477-478. 10.3109\/0284186X.2011.555781.","journal-title":"Acta Oncol"},{"key":"392_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ics.2004.11.065","volume":"1278","author":"V Scaioli","year":"2005","unstructured":"Scaioli V, Caraceni A, Martini C, Micco A, Curzi S, Capri G, Luca G: Visual electrophysiological evaluation in paclitaxel-treated patients. Pathophysiological mechanisms involved in retinal and optic nerve dysfunctions. Int Congress Ser. 2005, 1278: 37-40.","journal-title":"Int Congress Ser"},{"issue":"15","key":"392_CR18","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1093\/jnci\/87.15.1169","volume":"87","author":"L Gianni","year":"1995","unstructured":"Gianni L, Munzone E, Capri G, Villani F, Spreafico C, Tarenzi E, Fulfaro F, Caraceni A, Martini C, Laffranchi A, Valagussa P, Bonadonna G: Paclitaxel in metastatic breast cancer: a trial of Two doses by a 3-hour infusion in patients with disease recurrence after prior therapy with anthracyclines. J Natl Cancer Inst. 1995, 87 (15): 1169-1175. 10.1093\/jnci\/87.15.1169.","journal-title":"J Natl Cancer Inst"},{"key":"392_CR19","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1200\/JCO.1994.12.8.1741","volume":"12","author":"AD Seidmann","year":"1994","unstructured":"Seidmann AD, Barrett S, Canezo S: Photopsia during 3-hour paclitaxel administration at doses\u2009>\u2009250mg\/m2 [letter]. J Clin Oncol. 1994, 12: 1741-1742.","journal-title":"J Clin Oncol"},{"key":"392_CR20","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1023\/A:1008249230056","volume":"8","author":"LS Hofstra","year":"1997","unstructured":"Hofstra LS, de Vries EGE, Willemse PHB: Ophthalmic toxicity following paclitaxel infusion. Ann Oncol. 1997, 8: 1053-1054.","journal-title":"Ann Oncol"},{"key":"392_CR21","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/sj.bmt.1701913","volume":"24","author":"DW Johnson","year":"1999","unstructured":"Johnson DW, Cagnoni PJ, Schossau TM, Stemmer SM, Grayeb DE, Baron AE, Shpall EJ, Bearman SI, McDermitt J, Jones RB: Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support. Bone Marrow Trans. 1999, 24: 785-792. 10.1038\/sj.bmt.1701913.","journal-title":"Bone Marrow Trans"},{"key":"392_CR22","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/WNO.0b013e3181d8e4af","volume":"30","author":"KT Berg","year":"2010","unstructured":"Berg KT, Nelson B, Harrison AR, McLoon LK, Lee MS: Pegylated interferon alpha-associated optic neuropathy. J Neuroophthalmol. 2010, 30: 117-122. 10.1097\/WNO.0b013e3181d8e4af.","journal-title":"J Neuroophthalmol"},{"key":"392_CR23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11060-007-9438-8","volume":"86","author":"A Caraceni","year":"2008","unstructured":"Caraceni A, Miccoli P, Martini C, Curzi S, Cresta S, Gianni L, Scaioli V: Peripheral neuropathy due to pacliteaxel: study of the temporal reltionships between the therapeutic schedule and the clinical quantitative score and comparison with neurophysiological findings. J Neurooncol. 2008, 86: 89-99. 10.1007\/s11060-007-9438-8.","journal-title":"J Neurooncol"},{"key":"392_CR24","first-page":"107","volume":"15","author":"EK Rowinsky","year":"1993","unstructured":"Rowinsky EK, Chaudhry V, Cornblath DR, Donehower RC: The neurotoxicity of taxol. Monogr Natl Cancer Inst. 1993, 15: 107-115.","journal-title":"Monogr Natl Cancer Inst"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2415-14-18\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2415-14-18.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:12:57Z","timestamp":1548213177000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/1471-2415-14-18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,24]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["392"],"URL":"https:\/\/doi.org\/10.1186\/1471-2415-14-18","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,24]]},"article-number":"18"}}